ATE458727T1 - Zur modulation des 5-ht6-rezeptors, des 5-ht2a- rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane - Google Patents
Zur modulation des 5-ht6-rezeptors, des 5-ht2a- rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxaneInfo
- Publication number
- ATE458727T1 ATE458727T1 AT05734404T AT05734404T ATE458727T1 AT E458727 T1 ATE458727 T1 AT E458727T1 AT 05734404 T AT05734404 T AT 05734404T AT 05734404 T AT05734404 T AT 05734404T AT E458727 T1 ATE458727 T1 AT E458727T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor
- arylsulfonylbenzodioxanes
- receptors
- modulation
- ht2a
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56831404P | 2004-05-05 | 2004-05-05 | |
| PCT/EP2005/004479 WO2005105776A1 (en) | 2004-05-05 | 2005-04-27 | Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE458727T1 true ATE458727T1 (de) | 2010-03-15 |
Family
ID=34965191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05734404T ATE458727T1 (de) | 2004-05-05 | 2005-04-27 | Zur modulation des 5-ht6-rezeptors, des 5-ht2a- rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7368567B2 (de) |
| EP (1) | EP1748995B1 (de) |
| JP (1) | JP2007536302A (de) |
| KR (1) | KR100823805B1 (de) |
| CN (1) | CN100540546C (de) |
| AR (1) | AR048936A1 (de) |
| AT (1) | ATE458727T1 (de) |
| AU (1) | AU2005238179B2 (de) |
| BR (1) | BRPI0510642A (de) |
| CA (1) | CA2566196A1 (de) |
| DE (1) | DE602005019562D1 (de) |
| ES (1) | ES2338668T3 (de) |
| HK (1) | HK1104533A1 (de) |
| IL (1) | IL178819A0 (de) |
| MX (1) | MXPA06012621A (de) |
| NO (1) | NO20065510L (de) |
| NZ (1) | NZ550441A (de) |
| RU (1) | RU2372344C2 (de) |
| TW (1) | TWI298636B (de) |
| WO (1) | WO2005105776A1 (de) |
| ZA (1) | ZA200608588B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2643615T3 (es) * | 2004-09-30 | 2017-11-23 | F. Hoffmann-La Roche Ag | Composiciones y métodos para el tratamiento de trastornos cognitivos |
| CN101119989B (zh) * | 2004-12-21 | 2010-06-09 | 弗·哈夫曼-拉罗切有限公司 | 色满衍生物及其在治疗cns疾病中的用途 |
| BRPI0610046A2 (pt) * | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de benzodioxano e benzodioxolano e usos destes |
| WO2007051735A1 (en) | 2005-11-03 | 2007-05-10 | F. Hoffmann-La Roche Ag | Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
| WO2007120596A1 (en) * | 2006-04-12 | 2007-10-25 | Wyeth | DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS |
| AU2007263076A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonyl naphthalene derivatives and uses thereof |
| FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
| MX2010011724A (es) | 2008-04-29 | 2010-11-30 | Nsab Af Neurosearch Sweden Ab | Moduladores de neurotransmision de dopamina. |
| JP2011519839A (ja) * | 2008-04-29 | 2011-07-14 | エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ | ドーパミン神経伝達のモジュレーター |
| US8492372B2 (en) | 2008-04-29 | 2013-07-23 | Integrated Research Laboratories Sweden Ab | Modulators of dopamine neurotransmission |
| CN114890978B (zh) * | 2022-04-19 | 2023-07-25 | 宿迁医美科技有限公司 | 酚类化合物及其制备方法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3901814A1 (de) | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| TW224941B (de) * | 1989-11-08 | 1994-06-11 | Yamanouchi Pharma Co Ltd | |
| US5506192A (en) | 1990-06-07 | 1996-04-09 | Sandoz Ltd. | Substituted phthalides and heterocyclic phthalides |
| JP3210665B2 (ja) | 1990-07-27 | 2001-09-17 | 中外製薬株式会社 | 新規なベンゾピラン誘導体 |
| US5401848A (en) | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
| US5817693A (en) | 1991-11-05 | 1998-10-06 | Cousins; Russell Donovan | Endothelin receptor antagonists |
| ZA93436B (en) | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
| KR100231634B1 (ko) | 1992-08-17 | 1999-11-15 | 나가야마 오사무 | 벤조피란 및 벤족사진 유도체 |
| US5374643A (en) | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
| GB9309716D0 (en) * | 1993-05-12 | 1993-06-23 | Zeneca Ltd | Heterocyclic derivatives |
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| US6150402A (en) | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
| US5869478A (en) | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| PL324319A1 (en) | 1995-06-30 | 1998-05-25 | Upjohn Co | 1,6-disubstituted isochromates for fighting against sick headaches |
| US5663194A (en) | 1995-07-25 | 1997-09-02 | Mewshaw; Richard E. | Chroman-2-ylmethylamino derivatives |
| US5935958A (en) | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
| WO1998007418A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| US6559144B2 (en) | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
| CA2276278C (en) | 1997-02-27 | 2009-04-07 | Takeda Chemical Industries, Ltd. | Amine compounds, their production and use |
| TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
| FR2778662B1 (fr) | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| ES2213407T3 (es) | 1998-12-04 | 2004-08-16 | Takeda Chemical Industries, Ltd. | Derivados de benzofurano, procedimiento para su preparacion, y sus usos. |
| AU2001244700A1 (en) | 2000-04-03 | 2001-10-15 | Takeda Chemical Industries Ltd. | Process for producing amine derivatives |
| AR035858A1 (es) | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
| WO2003029239A1 (en) | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
| BR0213094A (pt) | 2001-10-04 | 2004-10-13 | Wyeth Corp | Derivados de cromano como ligandos de 5-hidroxi-triptamina-6 |
| DE60303376T2 (de) * | 2002-05-13 | 2006-11-16 | F. Hoffmann-La Roche Ag | Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen |
| JP4754821B2 (ja) | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物 |
| WO2005037223A2 (en) | 2003-10-15 | 2005-04-28 | Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
| AU2004283313A1 (en) | 2003-10-24 | 2005-05-06 | Exelixis, Inc. | TAO kinase modulators and methods of use |
-
2005
- 2005-04-27 AT AT05734404T patent/ATE458727T1/de not_active IP Right Cessation
- 2005-04-27 WO PCT/EP2005/004479 patent/WO2005105776A1/en active Application Filing
- 2005-04-27 ES ES05734404T patent/ES2338668T3/es active Active
- 2005-04-27 RU RU2006138180/04A patent/RU2372344C2/ru not_active IP Right Cessation
- 2005-04-27 EP EP05734404A patent/EP1748995B1/de active Active
- 2005-04-27 AU AU2005238179A patent/AU2005238179B2/en not_active Ceased
- 2005-04-27 KR KR1020067023073A patent/KR100823805B1/ko not_active IP Right Cessation
- 2005-04-27 CA CA002566196A patent/CA2566196A1/en not_active Abandoned
- 2005-04-27 CN CNB2005800143682A patent/CN100540546C/zh not_active Expired - Fee Related
- 2005-04-27 NZ NZ550441A patent/NZ550441A/en unknown
- 2005-04-27 DE DE602005019562T patent/DE602005019562D1/de active Active
- 2005-04-27 JP JP2007511952A patent/JP2007536302A/ja not_active Ceased
- 2005-04-27 BR BRPI0510642-7A patent/BRPI0510642A/pt not_active IP Right Cessation
- 2005-04-27 MX MXPA06012621A patent/MXPA06012621A/es active IP Right Grant
- 2005-05-02 AR ARP050101740A patent/AR048936A1/es unknown
- 2005-05-03 TW TW094114308A patent/TWI298636B/zh not_active IP Right Cessation
- 2005-05-04 US US11/121,873 patent/US7368567B2/en not_active Expired - Fee Related
-
2006
- 2006-10-13 ZA ZA200608588A patent/ZA200608588B/en unknown
- 2006-10-23 IL IL178819A patent/IL178819A0/en unknown
- 2006-11-29 NO NO20065510A patent/NO20065510L/no not_active Application Discontinuation
-
2007
- 2007-09-05 HK HK07109656.9A patent/HK1104533A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005019562D1 (de) | 2010-04-08 |
| ZA200608588B (en) | 2008-06-25 |
| ES2338668T3 (es) | 2010-05-11 |
| NO20065510L (no) | 2007-01-12 |
| AU2005238179A1 (en) | 2005-11-10 |
| IL178819A0 (en) | 2007-03-08 |
| MXPA06012621A (es) | 2006-12-15 |
| TW200605894A (en) | 2006-02-16 |
| JP2007536302A (ja) | 2007-12-13 |
| AU2005238179B2 (en) | 2010-08-26 |
| CN100540546C (zh) | 2009-09-16 |
| RU2006138180A (ru) | 2008-06-10 |
| KR20070009664A (ko) | 2007-01-18 |
| CA2566196A1 (en) | 2005-11-10 |
| NZ550441A (en) | 2009-07-31 |
| EP1748995A1 (de) | 2007-02-07 |
| WO2005105776A1 (en) | 2005-11-10 |
| KR100823805B1 (ko) | 2008-04-21 |
| EP1748995B1 (de) | 2010-02-24 |
| AR048936A1 (es) | 2006-06-14 |
| WO2005105776A8 (en) | 2007-01-11 |
| CN1960983A (zh) | 2007-05-09 |
| BRPI0510642A (pt) | 2007-11-20 |
| US20050250943A1 (en) | 2005-11-10 |
| HK1104533A1 (en) | 2008-01-18 |
| RU2372344C2 (ru) | 2009-11-10 |
| US7368567B2 (en) | 2008-05-06 |
| TWI298636B (en) | 2008-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE458727T1 (de) | Zur modulation des 5-ht6-rezeptors, des 5-ht2a- rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane | |
| ATE432056T1 (de) | Zervikale zwischenwirbelprothese | |
| HK1099019A1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| ATE428974T1 (de) | System zum automatischen erzeugen optimierter codes | |
| DE602004019389D1 (de) | Toner | |
| ATE382034T1 (de) | Hydroisoindolin-tachykininrezeptorantagonisten | |
| IL179462A0 (en) | Use of the receptor gpr86 | |
| DK2041093T3 (da) | Til behandling af GPR38-receptor medierede sygdomme anvendelige piperazinylderivativer | |
| EP1806147A4 (de) | Verwendung eines immunsuppressiven rezeptors | |
| FI7535U1 (fi) | Saniteettituote | |
| DK1814555T3 (da) | S-mirtazapin til behandling af hedeture | |
| DE502005000496D1 (de) | Verstellvorrichtung | |
| DK1896460T3 (da) | Benzofuranylderivater som 5-HT6-receptorinhibitorer | |
| IL185640A0 (en) | Use of 2-anilino-3 ,4-dihydro-quinazolines as 5ht5a receptor antagonists | |
| SE0400953L (sv) | Ortopedisk fotbeklädnad | |
| FI20041538A0 (fi) | Goniometri | |
| SE0400530L (sv) | Förfarande | |
| ES1056739Y (es) | Columbario para urnas de cenizas mortuorias. | |
| NO20043527L (no) | Rorkutter | |
| DE112005002293A5 (de) | Verstelleinrichtung | |
| ES1058317Y (es) | Kit para la fabricacion de balaustres. | |
| ES1058571Y (es) | Disposicion para la fijacion de balaustradas. | |
| ES1058540Y (es) | Dispositivo para la fijacion de sombrillas. | |
| ATE526016T1 (de) | Calcium-rezeptor-aktivator | |
| ES1058686Y (es) | Lamparita para la acumulacion de placton. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1748995 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |